Thursday, June 22, 2017 8:46:36 PM
I think too many investors... like myself... are tired of talk.. and want to see SCRIPTS BEING WRITTEN .... PERIOD...!! I have written how pathetic I believe both the 4k and the Rayaldee introductions have been... and it just doesn't seem to get management fired up.. statements like... OOPS we need twice as many sales people.. seem to me like after thoughts...
This is the first SHAREHOLDERS have seen of the number of SCRIPTS.. but from two earnings calls ago.. we heard that analyst thought it wasn't going as ... expected... SHAREHOLDERS in General.. had no idea of that... I don't find FROST very active in getting Shareholders TIMELY information before analysts decide to let their people know what to do... And Frost doesn't seem to have a sense of urgency... Hey.. we all know the only way for him to be able to sell his large stake is during a take over... And frankly... I don't think he cares what the price is until he is ready to sell... Think about it... the cheaper it is ... the more he can buy for the same $$$... So while the development of the company on a long term is in both His and the common shareholders interest... Delays... don't seem to matter to him as much as those of us who would like to se a return after 5 years...+ !! For me this is still my largest holding... and thus have taken a bath with all the delays over the last year or so... !! And am tired.. so am reducing what I have... I have another Bio.. That I feel is more Is more in line with giving shareholders profits as it goes along... rather than waiting.. for the big EVENT.. today... it was up another 4.8 % and I am doing better over the last year on that one... so... am selling off small sells of OPK and moving the money... I normally sell 200-500 shares at a time... so it doesn't really have an impact... on OPK..
Bottom Line... also.. I was a product manager in a large Corporation and grew a business from about 3m to 33M.... And delays weren't acceptable to me... nor my management.. And we needed a return every year... I dealt with sales.. and customers as well as product development.... and the DELAYS AND UNKNOWNS SEEMINGLY here.. just are not acceptable to most IMO.... Poor management. I wish they would farm out all the marketing and product introduction.. since it seems when a company who wants to make money NOW... gets it.. OPK shareholders see returns faster... than some PHd, or Md trying to manage a marketing and sales effort... again... JUST IMHO !! But look at our past deals...
Good luck... and maybe the new added sales team plus the announcement today... will start bringing in more $$$ to OPK shareholders.....
Recent OPK News
- OPKO Health to Report First Quarter 2024 Financial Results on May 7, 2024 • GlobeNewswire Inc. • 05/03/2024 12:00:00 PM
- Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business • PR Newswire (US) • 03/28/2024 12:00:00 PM
- Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome • GlobeNewswire Inc. • 03/20/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/07/2024 09:02:37 PM
- AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV • GlobeNewswire Inc. • 03/05/2024 01:52:22 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 09:05:23 PM
- NextPlat Opens OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China on March 1st • PR Newswire (US) • 02/28/2024 02:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:07:54 PM
- OPKO Health Reports Fourth Quarter 2023 Business Highlights and Financial Results • GlobeNewswire Inc. • 02/27/2024 09:05:00 PM
- OPKO Health to Report Fourth Quarter 2023 Financial Results on February 27, 2024 • GlobeNewswire Inc. • 02/22/2024 09:05:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/16/2024 09:53:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 09:07:24 PM
- NextPlat Receives Initial Approvals to Launch OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China • PR Newswire (US) • 02/05/2024 01:09:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/29/2024 08:30:14 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 01/24/2024 09:15:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 09:00:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 10:09:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/10/2024 10:56:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 10:09:07 PM
- OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser’s Option to Purchase Additional Notes • GlobeNewswire Inc. • 01/09/2024 09:05:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/08/2024 02:10:34 PM
- OPKO Health to Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/08/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 10:26:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:00:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 06:39:36 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM